Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA.
Arch Pathol Lab Med. 2010 Sep;134(9):1276-81. doi: 10.5858/2009-0178-RS.1.
MicroRNAs (miRNAs) are a family of 19- to 24-nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hematopoiesis.
微小 RNA(miRNA)是一类 19 到 24 个核苷酸的非编码 RNA,可在转录后和翻译水平调节信使 RNA 的功能。最近的文献表明 miRNA 在正常和恶性造血中具有重要作用。已经证明特定的 miRNA 可以调节造血的每个步骤,从多能祖细胞水平开始,一直到髓系和淋巴系分化的终末阶段。同样,个别 miRNA 和 miRNA 特征与特定的血液系统恶性肿瘤有关。越来越多的证据表明,miRNA 可用于诊断、预后和治疗目的。本综述重点介绍了 miRNA 在正常和恶性造血中的最新研究进展。